This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: University of Pennsylvania. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Haig Aghajanian: Innovator in Heart Disease Treatment
Introduction
Haig Aghajanian is a notable inventor based in Lafayette Hill, PA (US). He has made significant contributions to the field of medical science, particularly in the treatment of heart disease. His innovative approach utilizes advanced immunotherapy techniques to address critical health issues.
Latest Patents
Aghajanian holds a patent for "Methods for treating heart disease via redirected T cell immunotherapies." This invention includes compositions and methods for treating heart disease and/or heart failure. In one embodiment, the treatment involves administering a cell genetically modified to express a chimeric antigen receptor (CAR), which has an antigen binding domain specific for fibroblast activation protein (FAP). In another embodiment, the treatment includes administering a cell genetically modified to express a T cell receptor (TCR) specific for an activated fibroblast. He has 1 patent to his name.
Career Highlights
Aghajanian is affiliated with the University of Pennsylvania, where he continues to advance his research and innovations in the medical field. His work is pivotal in developing new therapies that could potentially save lives and improve the quality of care for patients with heart conditions.
Collaborations
Some of his notable coworkers include Jonathan A Epstein and Steven M Albelda. Their collaborative efforts contribute to the ongoing research and development of innovative treatments in the field of cardiology.
Conclusion
Haig Aghajanian is a distinguished inventor whose work in heart disease treatment exemplifies the intersection of innovation and healthcare. His contributions are vital in the pursuit of effective therapies for heart-related ailments.